Category

ECM

Daily Brief ECM: Xtep International Placement – Parent Trimming at ATHs and more

By | Daily Briefs, ECM

In today’s briefing:

  • Xtep International Placement – Parent Trimming at ATHs, Last Deal Didn’t Do Well
  • WCP IPO: Additional Important Considerations
  • Signature Global (India) Pre-IPO Tearsheet
  • Pre-IPO Best Wellness Innovation Group – Here Are the Concerns

Xtep International Placement – Parent Trimming at ATHs, Last Deal Didn’t Do Well

By Clarence Chu

  • Group Success Investments is looking to raise up to US$133m by trimming its holdings in Xtep International (1368 HK).
  • We can’t say that the deal is expected and short interest on the stock hasn’t been creeping up as well. 
  • While the deal won’t be a large one, representing just 5.7 days of three month ADV, the firm’s last deal hasn’t done well.

WCP IPO: Additional Important Considerations

By Douglas Kim

  • We remain Bearish on the WCP IPO. Our base case valuation of WCP is implied market cap of 3.0 trillion won and target price of 87,805 won per share.
  • In this insight, we highlight four additional important considerations to the WCP IPO including comparison to SK IE Technology, 1Q22 earnings comparison, higher IPO discount, and overly optimistic EBITDA estimates. 
  • We would categorize WCP as an excellent company but not exceptional as HPSP. Therefore, the weak market conditions will likely have a negative impact on the WCP IPO pricing.

Signature Global (India) Pre-IPO Tearsheet

By Clarence Chu

  • SignatureGlobal India Pvt Ltd (1468641D IN) is looking to raise around US$125m in its upcoming India IPO. The deal will be run by Axis, ICICI, and Kotak.
  • Signature Global is a real estate development company in India, with its primary operations being the development of residential real estate projects in the affordable and mid segment.
  • As of FY22, it had completed five projects with a land area of 34.9 acres and an aggregate saleable area of 2.86m sqft.

Pre-IPO Best Wellness Innovation Group – Here Are the Concerns

By Xinyao (Criss) Wang

  • The growth in revenue and profit was mainly driven by the face mask business, but this business has ceased, which raises the concerns on future growth momentum of Best Wellness.
  • Best Wellness’s weak performance of its own-brand business would prevent it from standing out in the fierce market competition in the long term. 
  • Together with over-reliance on limited customers and the complex international relations, we are conservative about the Company’s outlook at the current stage.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief ECM: Tian Tu Capital Pre-IPO Tearsheet and more

By | Daily Briefs, ECM

In today’s briefing:

  • Tian Tu Capital Pre-IPO Tearsheet
  • Beneunder Pre-IPO – The Positives – Basking in the Sun
  • Bharat FIH IPO: Rife with Bottlenecks
  • Beneunder Pre-IPO – The Negatives – Doubts Remain, Including Related Party Dealings

Tian Tu Capital Pre-IPO Tearsheet

By Ethan Aw

  • Tian Tu Capital (1390587D CH) is looking to raise about US$500m in its upcoming Hong Kong IPO. The deal will be run by JP Morgan and Huatai International.
  • Tian Tu Capital is a private equity investor that invests in Chinese consumer brands/companies, managing capital for institutional investors and high-net worth individuals.  
  • Among the 205 portfolio companies it had invested in up to FY21 (Dec 31, 2021), 23 of them had reached a valuation of US$1bn at that date. 

Beneunder Pre-IPO – The Positives – Basking in the Sun

By Sumeet Singh

  • Beneunder Limited (BL) aims to raise around US$500m in its Hong Kong IPO.
  • According to CIC, it was the largest sunprotection apparel brand in China in terms of both total retail sales value and online retail sales value with 5.0% and 12.9% marketshare. 
  • In this note, we will talk about the positive aspects of the deal.

Bharat FIH IPO: Rife with Bottlenecks

By Arun George

  • Bharat FIH (BFIH IN) is India’s largest Electronic Manufacturing Services (EMS) provider and the largest mobile phone manufacturing and assembly services provider to Xiaomi Corp (1810 HK)
  • It has received Sebi approval for an IPO to raise Rs50,038 million (US$625 million), split equally between a primary and secondary raise. The offer will launch in August. 
  • The fundamentals are challenged due to its reliance on Xiaomi, market share pressure, glacial revenue diversification, low margin and cash burn. We would pass on the IPO.

Beneunder Pre-IPO – The Negatives – Doubts Remain, Including Related Party Dealings

By Sumeet Singh

  • Beneunder Limited (BL) aims to raise around US$500m in its Hong Kong IPO.
  • According to CIC, it was the largest sunprotection apparel brand in China in terms of both total retail sales value and online retail sales value with 5.0% and 12.9% marketshare. 
  • In this note, we will talk about the not-so-positive aspects of the deal.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief ECM: Sebit Chem IPO Preview – A Major Competitor to Sungeel Hitech in Rechargeable Batteries Recycling and more

By | Daily Briefs, ECM

In today’s briefing:

  • Sebit Chem IPO Preview – A Major Competitor to Sungeel Hitech in Rechargeable Batteries Recycling
  • Soosan Industries IPO Book Building Results
  • Healthvista India Pre-IPO Tearsheet
  • Beijing UBOX Online Technology Pre-IPO – Trimming Losses, but yet to Factor in 2022 Lockdowns
  • Sebit Chem Valuation Analysis

Sebit Chem IPO Preview – A Major Competitor to Sungeel Hitech in Rechargeable Batteries Recycling

By Douglas Kim

  • Sebit Chem is getting ready to complete its IPO in early August. The IPO price range is from 25,000 won to 30,000 won.
  • The IPO base deal size is from US$21 million to US$25 million. The expected market cap after the IPO is from 126 billion won to 151 billion won.
  • Sebit Chem is one of the competitors to Sungeel Hitech which completed a very successful IPO book building. Sebit Chem is also likely to enjoy strong demand among many investors. 

Soosan Industries IPO Book Building Results

By Douglas Kim

  • Soosan Industries had disappointing IPO book building results. The demand ratio from the institutional investors was 130 to 1 which is lower than some of the recent IPOs. 
  • The IPO price has been determined at 35,000 won. Soosan Industries is one of the leading companies in Korea for providing maintenance services for nuclear power plant equipment in Korea.
  • Our base case valuation of Soosan Industries is target price of 56,383 won per share, which is 61% higher than the IPO price of 35,000 won. 

Healthvista India Pre-IPO Tearsheet

By Ethan Aw

  • Healthvista India (1370230D IN) is looking to raise about US$126m in its upcoming India IPO. The deal will be run by SBI Cap, IIFL Securities and JM Financial.
  • Healthvista India is an out-of-hospital healthcare service provider. Under its brand Portea, it offers services such as primary care, geriatric and palliative care, amongst others. 
  • It also distributes specialty pharmaceuticals and provides “point of care” medical equipment for sale and rental.

Beijing UBOX Online Technology Pre-IPO – Trimming Losses, but yet to Factor in 2022 Lockdowns

By Clarence Chu

  • Beijing UBOX Online Technology (1741985D CH) is looking to raise up to US$500m in its upcoming Hong Kong IPO. 
  • Beijing UBOX Online Technology (UBOX) is an unmanned retail operator (vending machine) in China. 
  • As per F&S, it was the largest unmanned retail operator in China, with the largest retail machine network in the country. 

Sebit Chem Valuation Analysis

By Douglas Kim

  • Our base case valuation of Sebit Chem IPO is target price of 50,775 won which is 69% higher than the high end of the IPO price range. 
  • Sebit Chem’s business is now mainly composed of recycling waste rechargeable batteries and waste acid (mostly from semiconductor and LCD related products).
  • Our base case valuation is based on 23.7x P/E (comps’ average) using our estimated net profit of 10.8 billion won in 2023. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief ECM: ANZ Bank (ANZ AU) Nixes MYOB and more

By | Daily Briefs, ECM

In today’s briefing:

  • ANZ Bank (ANZ AU) Nixes MYOB, Yeas SunCorp Bank, To Raise A$3.5bn of Equity
  • ANZ Renounceable Entitlement Offer – Dilute Now, Accrete Later. Still Appears Better than MYOB
  • SoCar IPO – Refiling Updates – Latest Earnings Do Not Change Investment Thesis
  • Air Closet Files for IPO
  • Super Hi Spin-Off: Unexciting Fundamentals

ANZ Bank (ANZ AU) Nixes MYOB, Yeas SunCorp Bank, To Raise A$3.5bn of Equity

By Travis Lundy

  • Australia and New Zealand Banking Group (ANZ) (ANZ AU) this morning made a flurry of announcements. First and foremost, ANZ withdrew from discussions on MYOB.
  • Q3 earnings ended 30 June saw revenue +5%, lending up 3%yoy, markets revenue +7%, NIM up 3bp (rising rates helps). Basel3 APRA Level2/Level1 CET1 Ratios were 11.1%/10.4%. 
  • But the big news: ANZ is buying SunCorp Bank from SunCorp (SUN AU) for A$4.9bn (1.3x NTA), and will raise A$3.5bn through a 1 for 15 renounceable rights offering.

ANZ Renounceable Entitlement Offer – Dilute Now, Accrete Later. Still Appears Better than MYOB

By Sumeet Singh

  • ANZ aims to raise around US$2.4bn (A$3.5bn) via a renounceable entitlement offer to part fund the purchase of Suncorp Bank.
  • In our view, neither the fundraising nor the acquisition appear to be particularly well flagged. ANZ’s withdrawal from MYOB talks might be the most positive thing about the announcement.
  • In this note, we will talk about the deal dynamics and run the deal through our ECM framework.

SoCar IPO – Refiling Updates – Latest Earnings Do Not Change Investment Thesis

By Ethan Aw

  • SOCAR (403550 KS)  is looking to raise up to US$157m in its upcoming Korea IPO. 
  • SoCar is a Korean car sharing business which aims to become an all-in-one mobility solutions provider beyond car sharing, with approximately 80% domestic market share in the car sharing space.
  • The firm remains loss-making with no signs of being profitable in the near/medium term. In this note, we will take a look at its refiling updates.

Air Closet Files for IPO

By Michael Causton

  • Subscription rental services have become increasingly mainstream and the earlier start ups are now maturing into larger businesses. One of the first, Air Closet, plans an IPO later this month. 
  • Air Closet specialises in renting out clothing from major labels but also in taking away the burden of choice by arranging for styles to be picked in-house.
  • As well as this growing service, Air Closet has also just launched a rental service for gadgets ranging from kitchen appliances to cameras.

Super Hi Spin-Off: Unexciting Fundamentals

By Ke Yan, CFA, FRM

  • Haidilao International announced the spin-off plan of its overseas arm, Super Hi.
  • We take a quick look at Super Hi’s fundamentals. We think it is unlikely for Super Hi to achieve the level of economy of scale as Haidilao in China.
  • We think the valuation of Super Hi should be compared to F&B peers in the ASEAN region given that its business is mainly focused on the ASEAN region. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief ECM: Pre-IPO Cryofocus Medtech (Shanghai) – The Industry and more

By | Daily Briefs, ECM

In today’s briefing:

  • Pre-IPO Cryofocus Medtech (Shanghai) – The Industry, the Business and the Concerns

Pre-IPO Cryofocus Medtech (Shanghai) – The Industry, the Business and the Concerns

By Xinyao (Criss) Wang

  • The cryoablation market accounts for about 1/3 of the total tumor ablation market overseas, while this percentage is less than 1/10 in China, indicating promising growth potential in the future.
  • Cryofocus Medtech (Shanghai) (CFM HK)’s products and candidates do have technical advantages, offering more choices for patients and doctors.
  • However, the commercialization outlook remains to be seen because of the potential large price reduction after entering national medical insurance coverage and the uncertainties over acceptance by patients and doctors.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief ECM: Socar IPO: Slightly Revises IPO Prospectus Details and more

By | Daily Briefs, ECM

In today’s briefing:

  • Socar IPO: Slightly Revises IPO Prospectus Details
  • ECM Weekly (17th Jul 2022) – Tianqi, Emperador, Soosan, SoCar, WCP, Deewin, Bharat FIH, BYD

Socar IPO: Slightly Revises IPO Prospectus Details

By Douglas Kim

  • SOCAR revised its IPO prospectus. What has changed is the date when the book building for the institutional investors starts (4 August). 
  • The IPO price range remains at 34,000 won to 45,000 won. The IPO base offering size is also between US$120 million to US$159 million. 
  • We maintain our base case valuation of Socar (target price of 27,967 won), which is 18% lower than the low end of the IPO price range of 34,000 won. 

ECM Weekly (17th Jul 2022) – Tianqi, Emperador, Soosan, SoCar, WCP, Deewin, Bharat FIH, BYD

By Sumeet Singh

  • Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
  • Tianqi’s soggy debut in Hong Kong despite its wide discount will probably put Hong Kong ECM back in snooze mode for a while
  • There were no major placements this week and its likely to remain that was as we approach the half-yearly results season.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief ECM: SOCAR Revised Prospectus: Critical Issues Still Not Addressed and more

By | Daily Briefs, ECM

In today’s briefing:

  • SOCAR Revised Prospectus: Critical Issues Still Not Addressed
  • WCP IPO: Valuation Insights

SOCAR Revised Prospectus: Critical Issues Still Not Addressed

By Sanghyun Park

  • There must be a rationale for car sharing to receive a higher valuation than the traditional rental car business. For this, profit per vehicle must be provided, not sales.
  • Also, whether SOCAR can justify its valuation built on the relatively high valuation premiums granted to ccOS and FMS companies is still questionable.
  • Concerning fund flow, it is positive that SOCAR can aim for LG Energy’s six-month lockup release. But it is unclear how much flow will be left for SOCAR after WCP.

WCP IPO: Valuation Insights

By Arun George

  • WCP (WCP KS), a lithium-ion batteries separator company, is planning to launch a KRW900 billion (US$692 million) IPO in August.
  • In WCP IPO: Hooked on Lithium we noted that WCP has attractive fundamentals due to the favourable demand/supply balance, technology, strong revenue growth and improving margins. 
  • In this note, we look at the syndicate’s valuation methodology. Our valuation analysis suggests that the IPO price range is unattractive and we would pass on the IPO.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief ECM: Sungeel HiTech IPO – The Highest Ever Bookbuilding Demand Ratio for a Korean IPO and more

By | Daily Briefs, ECM

In today’s briefing:

  • Sungeel HiTech IPO – The Highest Ever Bookbuilding Demand Ratio for a Korean IPO
  • Deewin Tianxia IPO Trading – Weak Subscription Rates, Retail Portion Undersubscribed
  • Bharat FIH Pre-IPO – The Negatives – Not a Whole Lot to Show Yet
  • Innova Captab Pre-IPO Tearsheet
  • WCP IPO – The Negatives – Patent, Going Concern, Customer Concentration

Sungeel HiTech IPO – The Highest Ever Bookbuilding Demand Ratio for a Korean IPO

By Douglas Kim

  • Sungeel Hitech announced its IPO book building results. The IPO price has been determined at 50,000 won, higher than the high end of IPO price of 47,500 won.
  • The demand ratio for Sungeel Hitech IPO was 2,269.7 to 1 which broke all time records in terms of highest ever demand ratio for a Korean IPO.
  • Our base case valuation is implied price per won of 70,992 won per share, which represents 42% higher than the IPO price of 50,000 won.

Deewin Tianxia IPO Trading – Weak Subscription Rates, Retail Portion Undersubscribed

By Clarence Chu

  • Deewin Tianxia (2418 HK) raised around US$123m in its Hong Kong IPO.
  • DT’s subscription rates had been lackluster with weak coverage on the institutional tranche and the retail portion being undersubscribed.
  • Given its smaller size, in our view, the firm should come in at a discount to its peer average.

Bharat FIH Pre-IPO – The Negatives – Not a Whole Lot to Show Yet

By Sumeet Singh

  • Bharat FIH (BFIH) aims to raise around US$660m in its India IPO via selling a mix of both primary and secondary shares. BFIH is a subsidiary of Foxconn.
  • Its initial operations were focused on mobile phones, of late it has been expanding its portfolio to include mechanics, electric vehicles, televisions and hearables. 
  • In this note, we will talk about the not so positive aspects of the deal.

Innova Captab Pre-IPO Tearsheet

By Ethan Aw

  • Innova Captab (1605221D IN)  is looking to raise about US$115m in its upcoming India IPO. The deal will be run by ICICI and JM Financial.
  • Innova Captab is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports. 
  • Its business includes a contract development and manufacturing organization (CDMO) business providing manufacturing services to Indian pharmaceutical companies, a domestic branded generics business and an international branded generics business.

WCP IPO – The Negatives – Patent, Going Concern, Customer Concentration

By Sumeet Singh

  • WCP aims to raise around US$690m via selling a mix of primary and secondary shares in its Korean IPO.
  • WCP designs, manufactures, and sells separators, which are one of the four core materials for secondary Lithium-ion batteries
  • In this note, we will talk about the not-so-positive aspects of the deal.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief ECM: WCP IPO: Hooked on Lithium and more

By | Daily Briefs, ECM

In today’s briefing:

  • WCP IPO: Hooked on Lithium
  • Giant Biogene Holding (GBH HK) Pre IPO: A Fundamentally Strong Company to Grab Market Opportunity
  • SML Group Pre-IPO Tearsheet
  • Growatt Technology Pre-IPO Tearsheet
  • WCP IPO – The Positives – Past Sales Have Been Very Strong

WCP IPO: Hooked on Lithium

By Arun George

  • WCP (WCP KS), a lithium-ion batteries separator company, is planning to launch a KRW900 billion (US$692 million) IPO in August.  
  • The price range of KRW80,000-100,000 implies a market cap of KRW2.7-3.4 trillion (US$2.1-2.6 billion).
  • WCP has attractive fundamentals due to the favourable demand/supply balance, technology, strong revenue growth and improving margins. 

Giant Biogene Holding (GBH HK) Pre IPO: A Fundamentally Strong Company to Grab Market Opportunity

By Tina Banerjee

  • Giant Biogene Holding (GBH HK) has filed for a Hong Kong IPO for raising as much as $1 billion. The company is China’s largest supplier of collagen-based skincare products.
  • Through its dual-pronged “medical institution + mass consumer” sales strategy, the company has increased revenue to RMB1,553 million in 2021 from RMB956.7 million in 2019.
  • The collagen-based skincare market in China is expected to grow from RMB9.4 billion in 2022 to RMB77.5 billion in 2027, at a CAGR of 52.6%, thereby offering significant growth opportunity.

SML Group Pre-IPO Tearsheet

By Clarence Chu

  • SML Group (SMLGZ HK) is looking to raise about US$200m in its upcoming Hong Kong IPO. The deal will be run by BNP Paribas.
  • SML Group (SMLG) is a vertically integrated digital identification solutions provider. It primarily engages in developing, manufacturing and selling label and tag products with RFID, a leading item-level identification technology.
  • SMLG operates globally across 24 countries and as of the latest practicable date (17 Jun 22), had 23 production facilities in 18 countries.

Growatt Technology Pre-IPO Tearsheet

By Ethan Aw

  • Growatt Technology (1833969D CH) is looking to raise about US$500m in its upcoming Hong Kong IPO. The deal will be run by Credit Suisse and CICC.
  • Growatt Technology is a global distributed energy solution provider, specializing in sustainable energy generation, storage and consumption and energy digitalization. 
  • As of the Latest Practicable Date (20 Jun 2022), they had shipped over 2.7m PV Inverters, 268,000 energy storage inverters. 

WCP IPO – The Positives – Past Sales Have Been Very Strong

By Sumeet Singh

  • WCP aims to raise around US$690m via selling a mix of primary and secondary shares in its Korean IPO.
  • WCP designs, manufactures, and sells separators, which are one of the four core materials for secondary Lithium-ion batteries
  • In this note, we will talk about the positive aspects of the deal.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief ECM: Tianqi Lithium H Share Listing: Trading Debut and more

By | Daily Briefs, ECM

In today’s briefing:

  • Tianqi Lithium H Share Listing: Trading Debut
  • SoCar IPO – Highly Competitive Market Coupled with Steep Valuations
  • Pre-IPO Huayiwang Technology – The Business Model Is Reasonable, but There Are Also Challenges
  • Bharat FIH Pre-IPO – The Positives – A Whole Lot of Promise

Tianqi Lithium H Share Listing: Trading Debut

By Arun George

  • Tianqi Lithium (002466 CH) priced its H Share at HK$82.00 per share to raise net proceeds of HK$13,062 million (US$1.7 billion). The H Share will start trading tomorrow.
  • The H Share listing (HK$82.00) and grey market price (HK$76.50) imply an AH discount of 45% and 49%, respectively. This compares to Ganfeng Lithium (1772 HK)’s current 35.3% AH discount.
  • The relative valuation is attractive. At the H Share listing price, Tianqi Lithium (9696 HK)’s H Share trades at a -6% discount to the median peers’ CY2022 P/B multiple.

SoCar IPO – Highly Competitive Market Coupled with Steep Valuations

By Ethan Aw

  • SOCAR (403550 KS) is looking to raise up to US$159m in its upcoming Korea IPO.
  • SoCar is a Korean car sharing business which aims to become an all-in-one mobility solutions provider beyond car sharing, with approximately 80% domestic market share in the car sharing space.
  • The firm remains loss-making with no signs of being profitable in the near/medium term. In this note, we will take a look at its valuations vs that of listed peers.

Pre-IPO Huayiwang Technology – The Business Model Is Reasonable, but There Are Also Challenges

By Xinyao (Criss) Wang

  • Huayiwang Technology (1985554D HK) is strong in its digital medical education solutions, which is the cornerstone business for the continuous expansion of other solution offerings and ecosystem.
  • HUAYIWANG charges service fees mainly from pharmaceutical companies, which could be a more sustainable profit model than charging from patients directly.
  • However, the increasing competition and potential risk of losing medical professionals could shake the foundations of HUAYIWANG’s business. 

Bharat FIH Pre-IPO – The Positives – A Whole Lot of Promise

By Sumeet Singh

  • Bharat FIH (BFIH) aims to raise around US$660m in its India IPO via selling a mix of both primary and secondary shares. BFIH is a subsidiary of Foxconn.
  • Its initial operations were focussed on mobile phones, of late it has been expanding its portfolio to include mechanics, electric vehicles, televisions and hearables. 
  • In this note, we will talk about the positive aspects of the deal.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars